Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J S Berek

Showing results (101-110 of 172) with videos related to

Pageof 18
Sort By:
Gynecologic Oncology|November 25, 1998
Combination of transforming growth factor beta antisense and interleukin-2 gene therapy in the murine ovarian teratoma modelO Dorigo, D L Shawler, I Royston, et al.
Gynecologic Oncology|January 1, 1986
Phase II trial of cisplatin in advanced or recurrent cancer of the vagina: a Gynecologic Oncology Group StudyJ T Thigpen, J A Blessing, H D Homesley, et al.
Climacteric : the Journal of the International Menopause Society|September 27, 2006
Response to commentaries on retention of the ovaries and long-term survival after hysterectomyW H Parker, M S Broder, Z Liu, et al.
Obstetrics and Gynecology|November 1, 1981
Radical vulvectomy and bilateral inguinal lymphadenectomy through separate groin incisionsN F Hacker, R S Leuchter, J S Berek, et al.
Gynecologic Oncology|September 1, 1990
Surgical-pathologic variables predictive of local recurrence in squamous cell carcinoma of the vulvaJ M Heaps, Y S Fu, F J Montz, et al.
Analytical and Quantitative Cytology and Histology|March 1, 1987
Prognostic significance of DNA ploidy and morphometric analyses of adenocarcinoma of the uterine cervixY S Fu, T L Hall, J S Berek, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 10, 1999
IL-2 plasmid therapy of murine ovarian carcinoma inhibits the growth of tumor ascites and alters its cytokine profileH M Horton, O Dorigo, P Hernandez, et al.
Obstetrics and Gynecology|February 1, 1984
Individualization of treatment for stage I squamous cell vulvar carcinomaN F Hacker, J S Berek, L D Lagasse, et al.
Obstetrics and Gynecology|February 1, 1983
Survival of patients following secondary cytoreductive surgery in ovarian cancerJ S Berek, N F Hacker, L D Lagasse, et al.
Obstetrics and Gynecology|November 1, 1988
Peritoneal cytology of ovarian cancer patients receiving intraperitoneal therapy: quantitation of malignant cells and responseS Sagae, J S Berek, Y S Fu, et al.
Pageof 18

Showing results (101-110 of 172) with videos related to

Sort By:
Pageof 18
Gynecologic Oncology|November 25, 1998
Combination of transforming growth factor beta antisense and interleukin-2 gene therapy in the murine ovarian teratoma modelO Dorigo, D L Shawler, I Royston, et al.
Gynecologic Oncology|January 1, 1986
Phase II trial of cisplatin in advanced or recurrent cancer of the vagina: a Gynecologic Oncology Group StudyJ T Thigpen, J A Blessing, H D Homesley, et al.
Climacteric : the Journal of the International Menopause Society|September 27, 2006
Response to commentaries on retention of the ovaries and long-term survival after hysterectomyW H Parker, M S Broder, Z Liu, et al.
Obstetrics and Gynecology|November 1, 1981
Radical vulvectomy and bilateral inguinal lymphadenectomy through separate groin incisionsN F Hacker, R S Leuchter, J S Berek, et al.
Gynecologic Oncology|September 1, 1990
Surgical-pathologic variables predictive of local recurrence in squamous cell carcinoma of the vulvaJ M Heaps, Y S Fu, F J Montz, et al.
Analytical and Quantitative Cytology and Histology|March 1, 1987
Prognostic significance of DNA ploidy and morphometric analyses of adenocarcinoma of the uterine cervixY S Fu, T L Hall, J S Berek, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 10, 1999
IL-2 plasmid therapy of murine ovarian carcinoma inhibits the growth of tumor ascites and alters its cytokine profileH M Horton, O Dorigo, P Hernandez, et al.
Obstetrics and Gynecology|February 1, 1984
Individualization of treatment for stage I squamous cell vulvar carcinomaN F Hacker, J S Berek, L D Lagasse, et al.
Obstetrics and Gynecology|February 1, 1983
Survival of patients following secondary cytoreductive surgery in ovarian cancerJ S Berek, N F Hacker, L D Lagasse, et al.
Obstetrics and Gynecology|November 1, 1988
Peritoneal cytology of ovarian cancer patients receiving intraperitoneal therapy: quantitation of malignant cells and responseS Sagae, J S Berek, Y S Fu, et al.
Pageof 18